Amprius Technologies (NYSE:AMPX) CTO Constantin Ionel Stefan Sells 39,690 Shares

Amprius Technologies, Inc. (NYSE:AMPXGet Free Report) CTO Constantin Ionel Stefan sold 39,690 shares of the business’s stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $12.00, for a total value of $476,280.00. Following the completion of the sale, the chief technology officer owned 748,696 shares of the company’s stock, valued at $8,984,352. This trade represents a 5.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Constantin Ionel Stefan also recently made the following trade(s):

  • On Friday, January 23rd, Constantin Ionel Stefan sold 1,600 shares of Amprius Technologies stock. The shares were sold at an average price of $12.00, for a total value of $19,200.00.
  • On Wednesday, January 21st, Constantin Ionel Stefan sold 73,280 shares of Amprius Technologies stock. The shares were sold at an average price of $12.00, for a total transaction of $879,360.00.
  • On Thursday, January 22nd, Constantin Ionel Stefan sold 492,827 shares of Amprius Technologies stock. The stock was sold at an average price of $12.04, for a total transaction of $5,933,637.08.
  • On Thursday, December 11th, Constantin Ionel Stefan sold 198,255 shares of Amprius Technologies stock. The stock was sold at an average price of $10.51, for a total transaction of $2,083,660.05.
  • On Friday, November 21st, Constantin Ionel Stefan sold 25,024 shares of Amprius Technologies stock. The shares were sold at an average price of $10.08, for a total transaction of $252,241.92.

Amprius Technologies Stock Down 8.5%

Shares of NYSE AMPX opened at $12.42 on Friday. The firm has a market cap of $1.62 billion, a price-to-earnings ratio of -47.77 and a beta of 3.04. The company’s 50-day simple moving average is $10.27 and its 200-day simple moving average is $10.02. Amprius Technologies, Inc. has a 52-week low of $1.70 and a 52-week high of $16.03.

Amprius Technologies (NYSE:AMPXGet Free Report) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $21.43 million during the quarter, compared to the consensus estimate of $16.45 million. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. Equities research analysts anticipate that Amprius Technologies, Inc. will post -0.45 EPS for the current fiscal year.

Trending Headlines about Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

  • Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
  • Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
  • Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
  • Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
  • Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
  • Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Analysts Set New Price Targets

A number of analysts have recently issued reports on AMPX shares. Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Needham & Company LLC began coverage on Amprius Technologies in a report on Thursday. They issued a “buy” rating and a $20.00 price objective on the stock. Cantor Fitzgerald lifted their target price on shares of Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research note on Friday, November 7th. Northland Securities set a $20.00 target price on shares of Amprius Technologies in a research report on Tuesday, October 7th. Finally, Roth Mkm set a $14.00 price target on shares of Amprius Technologies and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Seven equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $16.57.

Check Out Our Latest Report on Amprius Technologies

Institutional Trading of Amprius Technologies

Several large investors have recently added to or reduced their stakes in AMPX. Voloridge Investment Management LLC purchased a new position in shares of Amprius Technologies during the 3rd quarter worth $19,737,000. BNP Paribas Financial Markets grew its holdings in shares of Amprius Technologies by 1,117.9% in the third quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company’s stock valued at $20,450,000 after purchasing an additional 1,784,291 shares during the period. Vanguard Group Inc. increased its position in Amprius Technologies by 37.0% during the third quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company’s stock worth $68,513,000 after purchasing an additional 1,757,395 shares during the last quarter. Invesco Ltd. raised its stake in Amprius Technologies by 113.3% during the third quarter. Invesco Ltd. now owns 2,379,384 shares of the company’s stock worth $25,031,000 after purchasing an additional 1,263,846 shares during the period. Finally, Stephens Investment Management Group LLC purchased a new position in Amprius Technologies during the third quarter worth about $11,392,000. 5.04% of the stock is currently owned by hedge funds and other institutional investors.

About Amprius Technologies

(Get Free Report)

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

Read More

Insider Buying and Selling by Quarter for Amprius Technologies (NYSE:AMPX)

Receive News & Ratings for Amprius Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amprius Technologies and related companies with MarketBeat.com's FREE daily email newsletter.